{"id":"standard-of-care-antiretroviral-therapy","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Nausea and gastrointestinal disturbance"},{"rate":"5-20","effect":"Headache"},{"rate":"5-15","effect":"Fatigue"},{"rate":"5-20","effect":"Lipodystrophy (fat redistribution)"},{"rate":"5-15","effect":"Peripheral neuropathy"},{"rate":"2-10","effect":"Hepatotoxicity"},{"rate":"<1","effect":"Lactic acidosis (rare)"},{"rate":"10-25","effect":"Immune reconstitution inflammatory syndrome (IRIS)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Antiretroviral therapy typically combines multiple drug classes that work synergistically to block different stages of the HIV life cycle. Modern regimens usually include nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), or entry inhibitors. This multi-drug approach prevents viral replication, allows CD4+ T-cell recovery, and reduces transmission risk.","oneSentence":"Standard-of-care antiretroviral therapy suppresses HIV replication by targeting viral enzymes (reverse transcriptase, protease, integrase) and entry mechanisms to reduce viral load and restore immune function.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:28.357Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection (treatment and prevention)"},{"name":"AIDS (acquired immunodeficiency syndrome)"}]},"trialDetails":[{"nctId":"NCT06819176","phase":"PHASE1","title":"Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-01-20","conditions":"Human Immunodeficiency Virus","enrollment":50},{"nctId":"NCT04304768","phase":"PHASE4","title":"Opioid, HIV and Immune System","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2020-11-18","conditions":"Immune Defect","enrollment":400},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT00931463","phase":"PHASE4","title":"A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2009-09","conditions":"HIV Infections","enrollment":558},{"nctId":"NCT07053384","phase":"PHASE1","title":"A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2025-07-10","conditions":"HIV Infections","enrollment":107},{"nctId":"NCT07194902","phase":"NA","title":"HIV Self-testing for Partners of HIV-uninfected Postpartum Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-19","conditions":"HIV Self-testing, Male Partners of HIV-negative Postpartum Women, PrEP Uptake","enrollment":120},{"nctId":"NCT05994742","phase":"PHASE3","title":"An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-07-15","conditions":"Severe Acute Malnutrition, HIV, Comorbidities and Coexisting Conditions","enrollment":674},{"nctId":"NCT07466836","phase":"NA","title":"The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"Tyson Perez, DC, PhD","startDate":"2026-04","conditions":"Human Immunodeficiency Virus (HIV)","enrollment":40},{"nctId":"NCT05996471","phase":"PHASE2","title":"A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2023-08-17","conditions":"HIV Infections","enrollment":185},{"nctId":"NCT06629753","phase":"NA","title":"Differentiated Service Delivery for Pregnant and Postpartum Women Living With HIV and Their Infants","status":"COMPLETED","sponsor":"Indiana University","startDate":"2024-09-13","conditions":"Hiv, Transmission Vertical, Viremia","enrollment":278},{"nctId":"NCT07001319","phase":"PHASE1","title":"Study of GS-3242 in Participants With HIV-1; Substudy-05","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2025-05-29","conditions":"HIV-1-infection","enrollment":30},{"nctId":"NCT03133728","phase":"","title":"Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-05-30","conditions":"HIV Infections, Hiv","enrollment":1682},{"nctId":"NCT07428330","phase":"NA","title":"Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV","status":"RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-02-03","conditions":"Cervix Cancer, HIV Infections, HPV Infection","enrollment":1600},{"nctId":"NCT07439562","phase":"NA","title":"Choice-Based Support for Adults Starting or Restarting Antiretroviral Therapy in Cape Town, South Africa","status":"NOT_YET_RECRUITING","sponsor":"University of Cape Town","startDate":"2026-02","conditions":"HIV Care Loss to Followup","enrollment":140},{"nctId":"NCT05398185","phase":"NA","title":"WiseApp for Spanish Speakers Living With HIV","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-03-01","conditions":"HIV Infections, Acquired Immune Deficiency Syndrome, Sexually Transmitted Diseases, Viral","enrollment":248},{"nctId":"NCT05866523","phase":"NA","title":"Teamwork Makes the Dream Work","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2023-10-16","conditions":"HIV Infections, Inpatient Facility Diagnoses","enrollment":250},{"nctId":"NCT05393193","phase":"PHASE4","title":"POC HIV Testing and Early DTG Use for Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2022-07-04","conditions":"HIV","enrollment":900},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT04991402","phase":"","title":"Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir","status":"COMPLETED","sponsor":"Columbia University","startDate":"2021-09-21","conditions":"HIV, Obesity, Obesity, Infant","enrollment":1920},{"nctId":"NCT06886971","phase":"NA","title":"Strategies to AchieVe Viral Suppression for Youth With HIV","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-11-10","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":288},{"nctId":"NCT05208697","phase":"NA","title":"Tele-Harm Reduction","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2022-10-10","conditions":"IV Drug Usage, HIV Infections, Hepatitis C","enrollment":100},{"nctId":"NCT06394323","phase":"NA","title":"Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-08-06","conditions":"HIV Prevention","enrollment":132},{"nctId":"NCT07377760","phase":"NA","title":"Adaptive Text Messaging and Non-Monetary Incentives to Sustain ART Adherence Among Adolescents Living With HIV in Ethiopia","status":"NOT_YET_RECRUITING","sponsor":"Arba Minch University","startDate":"2026-03-09","conditions":"Antiretroviral Therapy (ART) Adherence Among Adolescents Living With HIV","enrollment":327},{"nctId":"NCT06541028","phase":"NA","title":"Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-11-04","conditions":"Hiv, Drug Use","enrollment":135},{"nctId":"NCT06814041","phase":"NA","title":"Pilot RCT and Interview Study on an HIV Chatbot in Nigeria","status":"ACTIVE_NOT_RECRUITING","sponsor":"Christoph Pimmer","startDate":"2025-04-14","conditions":"HIV","enrollment":314},{"nctId":"NCT06951542","phase":"NA","title":"HIV-Mental Illness Stigma Reduction and Outcomes in Malawi","status":"ENROLLING_BY_INVITATION","sponsor":"University of Pennsylvania","startDate":"2026-04-01","conditions":"Depression - Major Depressive Disorder, HIV, Health Condition Stigma","enrollment":200},{"nctId":"NCT03500172","phase":"NA","title":"HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-06-22","conditions":"HIV-1 Virologic Response","enrollment":1391},{"nctId":"NCT01790373","phase":"NA","title":"Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2013-09-07","conditions":"HIV","enrollment":702},{"nctId":"NCT07329166","phase":"NA","title":"Reducing Mobility-associated Interruption in HIV Treatment in Malawi","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-12-18","conditions":"HIV","enrollment":400},{"nctId":"NCT05121064","phase":"NA","title":"Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2023-01-24","conditions":"HIV/AIDS, Alcohol-Related Disorders, Mental Illness","enrollment":680},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT07215325","phase":"PHASE4","title":"Got Doxy- 'Flipping the Script' on STI PEP","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-10-22","conditions":"Sexually Transmitted Infections (STI)","enrollment":200},{"nctId":"NCT05841797","phase":"NA","title":"Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-06-05","conditions":"Human Immunodeficiency Virus","enrollment":120},{"nctId":"NCT05310773","phase":"NA","title":"Couples Health CoOp Plus","status":"COMPLETED","sponsor":"RTI International","startDate":"2022-05-06","conditions":"HIV, Substance Use, Stigma, Social","enrollment":962},{"nctId":"NCT05631093","phase":"PHASE3","title":"A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-02-20","conditions":"HIV-1 Infection","enrollment":553},{"nctId":"NCT07030920","phase":"PHASE2","title":"Reducing Systemic Inflammation in People on Antiretroviral Therapy","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-09-30","conditions":"Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor","enrollment":150},{"nctId":"NCT07235852","phase":"NA","title":"Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-09-15","conditions":"HIV Infections, Depression, Anxiety Disorders","enrollment":50},{"nctId":"NCT06630299","phase":"PHASE3","title":"Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-10-08","conditions":"HIV-1-Infection","enrollment":600},{"nctId":"NCT04793750","phase":"NA","title":"Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-08-18","conditions":"HIV Infections, Syphilis","enrollment":419},{"nctId":"NCT07115368","phase":"PHASE1","title":"Study of GS-1219 in Participants With HIV-1","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2025-08-11","conditions":"HIV-1-infection","enrollment":4},{"nctId":"NCT06061081","phase":"PHASE2","title":"A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1","status":"TERMINATED","sponsor":"ViiV Healthcare","startDate":"2023-12-21","conditions":"HIV Infections","enrollment":21},{"nctId":"NCT03981445","phase":"NA","title":"Integrated HIV Prevention and HCV Care for PWID","status":"ACTIVE_NOT_RECRUITING","sponsor":"Columbia University","startDate":"2019-11-14","conditions":"HIV Prevention, HCV, Opioid Use","enrollment":446},{"nctId":"NCT06497465","phase":"PHASE3","title":"Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-09-18","conditions":"Tuberculosis, HIV","enrollment":150},{"nctId":"NCT06056037","phase":"NA","title":"Making ART Work Among Brazilian Youth","status":"RECRUITING","sponsor":"Brown University","startDate":"2023-10-01","conditions":"Hiv, Adherence, Medication","enrollment":72},{"nctId":"NCT03508310","phase":"NA","title":"A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIV","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2016-06-01","conditions":"HIV Infections","enrollment":4003},{"nctId":"NCT03385473","phase":"NA","title":"Individualized Antiretroviral Therapy","status":"COMPLETED","sponsor":"Hospital Italiano de Buenos Aires","startDate":"2017-10-05","conditions":"Pharmacogenetics, HIV, Drug Monitoring","enrollment":190},{"nctId":"NCT02245022","phase":"PHASE2, PHASE3","title":"Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study","status":"COMPLETED","sponsor":"University of Liverpool","startDate":"2017-03-14","conditions":"HIV, Pregnancy","enrollment":60},{"nctId":"NCT03635788","phase":"PHASE3","title":"The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-03-28","conditions":"HIV Infections","enrollment":456},{"nctId":"NCT05110963","phase":"NA","title":"Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Connecticut","startDate":"2021-02-01","conditions":"HIV I Infection","enrollment":3771},{"nctId":"NCT07075146","phase":"PHASE3","title":"DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity","status":"RECRUITING","sponsor":"José Antonio Mata Marín","startDate":"2025-05-05","conditions":"HIV - Human Immunodeficiency Virus, Obesity, Overweight and/or Obesity","enrollment":306},{"nctId":"NCT06810973","phase":"NA","title":"Substance Use and HIV Action for Reentry and Engagement.","status":"ENROLLING_BY_INVITATION","sponsor":"Emory University","startDate":"2025-06-09","conditions":"HIV","enrollment":100},{"nctId":"NCT07110831","phase":"PHASE4","title":"Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria","status":"NOT_YET_RECRUITING","sponsor":"University of Ibadan","startDate":"2025-08-14","conditions":"Depression, HIV","enrollment":168},{"nctId":"NCT01741311","phase":"NA","title":"Secondary HIV Prevention and Adherence Among HIV-infected Drug Users","status":"COMPLETED","sponsor":"University of Connecticut","startDate":"2012-09","conditions":"Risk Behavior, Medication Adherence, HIV","enrollment":106},{"nctId":"NCT04266938","phase":"NA","title":"Impact of Rapid ART Initiation on Retention in Care in the Southern US","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2021-06-01","conditions":"HIV-1-infection","enrollment":258},{"nctId":"NCT05958017","phase":"NA","title":"reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-03-04","conditions":"Stimulant Use Disorder, People Living With HIV, reSET","enrollment":500},{"nctId":"NCT04527874","phase":"NA","title":"Viral Load Triggered ART Care in Lesotho","status":"COMPLETED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2020-10-14","conditions":"HIV Infections","enrollment":5809},{"nctId":"NCT02259127","phase":"PHASE2, PHASE3","title":"ODYSSEY (PENTA 20)","status":"COMPLETED","sponsor":"PENTA Foundation","startDate":"2016-09-20","conditions":"HIV Infection","enrollment":792},{"nctId":"NCT07064785","phase":"NA","title":"Video-Intervention to Inspire Treatment Adherence for Life for Adolescents","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2025-07-25","conditions":"HIV/AIDS","enrollment":1800},{"nctId":"NCT05729568","phase":"PHASE2","title":"A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2023-05-15","conditions":"HIV Infection","enrollment":83},{"nctId":"NCT04571684","phase":"NA","title":"Evaluating HITSystem 2.1 to Improve Viral Suppression in Kenya","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2020-10-05","conditions":"HIV, Pregnancy","enrollment":1639},{"nctId":"NCT06214052","phase":"PHASE2","title":"VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2024-02-07","conditions":"HIV Infections","enrollment":22},{"nctId":"NCT07031063","phase":"PHASE4","title":"Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-04-01","conditions":"HIV Infection, Metabolic Syndrome, Antiretroviral Treatment","enrollment":124},{"nctId":"NCT06428045","phase":"PHASE1","title":"STARLITE for Unresectable High-Grade Gliomas","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-04-15","conditions":"High Grade Glioma","enrollment":24},{"nctId":"NCT05585307","phase":"PHASE1","title":"Study of Novel Antiretrovirals in Participants With HIV-1","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2022-10-26","conditions":"HIV-1-infection","enrollment":49},{"nctId":"NCT03048669","phase":"NA","title":"Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2016-11","conditions":"HIV/AIDS, Antiretroviral Therapy, Pregnancy Outcomes","enrollment":5053},{"nctId":"NCT04026867","phase":"NA","title":"The DETECT HCV Linkage to Care Trial","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2019-11-20","conditions":"Hepatitis C","enrollment":309},{"nctId":"NCT03041012","phase":"PHASE2","title":"Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2017-01-20","conditions":"Hiv","enrollment":60},{"nctId":"NCT06926569","phase":"NA","title":"Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Public Health Clinical Center","startDate":"2025-05-01","conditions":"HIV/AIDS-associated Talaromycosis","enrollment":116},{"nctId":"NCT02515149","phase":"NA","title":"Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in Kenya","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2013-07","conditions":"HIV","enrollment":770},{"nctId":"NCT02935296","phase":"NA","title":"Integrated Treatment and Prevention for People Who Inject Drugs","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2015-02-04","conditions":"HIV Positive","enrollment":1281},{"nctId":"NCT03205696","phase":"","title":"Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-08-01","conditions":"Human Immunodeficiency Virus","enrollment":101},{"nctId":"NCT02663219","phase":"NA","title":"Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States","status":"COMPLETED","sponsor":"HIV Prevention Trials Network","startDate":"2016-06-06","conditions":"HIV","enrollment":144},{"nctId":"NCT02044484","phase":"NA","title":"HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2014-01","conditions":"HIV","enrollment":2794},{"nctId":"NCT05938803","phase":"NA","title":"PASEO Intervention for Adolescents Transitioning to Adult HIV Care in Urban Peru","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harvard University Faculty of Medicine","startDate":"2023-09-29","conditions":"HIV Infections","enrollment":160},{"nctId":"NCT06126913","phase":"NA","title":"HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-01-15","conditions":"HIV Infections, Hiv","enrollment":2720},{"nctId":"NCT04650269","phase":"PHASE4","title":"Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program","status":"COMPLETED","sponsor":"University of Miami","startDate":"2021-03-04","conditions":"Harm Reduction, HIV Infections, Drug Use","enrollment":27},{"nctId":"NCT04383769","phase":"","title":"Differentiated Service Delivery for Antiretroviral Therapy","status":"COMPLETED","sponsor":"Thai Red Cross AIDS Research Centre","startDate":"2019-12-15","conditions":"HIV Infections","enrollment":5000},{"nctId":"NCT06676410","phase":"PHASE2","title":"Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants","status":"RECRUITING","sponsor":"Code Pharma","startDate":"2023-07-20","conditions":"HIV, HIV Infection","enrollment":40},{"nctId":"NCT03848728","phase":"NA","title":"Strategic Antiretroviral Therapy and HIV Testing for Youth in Rural Africa","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-03-14","conditions":"HIV","enrollment":1988},{"nctId":"NCT04871113","phase":"PHASE2","title":"A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2021-06-22","conditions":"HIV Infections","enrollment":62},{"nctId":"NCT03555396","phase":"NA","title":"Couples ART Adherence Intervention for PWID in Kazakhstan","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-10-26","conditions":"HIV Infections, Substance Use Disorders","enrollment":132},{"nctId":"NCT06635421","phase":"","title":"The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV","status":"NOT_YET_RECRUITING","sponsor":"MetroHealth Medical Center","startDate":"2024-11-01","conditions":"HIV I Infection","enrollment":164},{"nctId":"NCT04222270","phase":"NA","title":"Caregiver Peer Support and ART Adherence Among Children","status":"COMPLETED","sponsor":"Institute of Human Virology, Nigeria","startDate":"2021-12-01","conditions":"HIV, Adherence","enrollment":96},{"nctId":"NCT02722421","phase":"PHASE2","title":"Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2017-04-06","conditions":"HIV, Contraception","enrollment":28},{"nctId":"NCT05592613","phase":"PHASE3","title":"Next Generation Ingestible Sensors for Medication Adherence Measurement","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2023-02-06","conditions":"HIV Infection, Adherence, Medication, Adherence, Treatment","enrollment":15},{"nctId":"NCT04233242","phase":"NA","title":"Genotype-Informed Versus Empiric Management of VirEmia","status":"COMPLETED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2020-03-03","conditions":"HIV-1-infection","enrollment":286},{"nctId":"NCT03158844","phase":"","title":"HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2017-05-16","conditions":"Hiv","enrollment":250},{"nctId":"NCT04201353","phase":"NA","title":"Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy Phase II","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2020-03-09","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":1984},{"nctId":"NCT03092531","phase":"NA","title":"Positive Steps to Enhance Problem Solving Skills","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2018-02-01","conditions":"Adherence","enrollment":123},{"nctId":"NCT03397576","phase":"NA","title":"Adherence Through Home Education and Nursing Assessment, Indonesia","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2017-02-27","conditions":"HIV/AIDS, Medication Adherence, Substance Use","enrollment":150},{"nctId":"NCT03600103","phase":"NA","title":"Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-07-11","conditions":"HIV Infections, Adherence, Medication","enrollment":76},{"nctId":"NCT04253119","phase":"","title":"ART First-line Treatment Durability in Russia","status":"COMPLETED","sponsor":"MSD Pharmaceuticals LLC","startDate":"2019-11-26","conditions":"HIV-1-infection","enrollment":536},{"nctId":"NCT03820323","phase":"NA","title":"Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-03-07","conditions":"Chronic HIV Infection","enrollment":704},{"nctId":"NCT05848427","phase":"","title":"The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19","status":"RECRUITING","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19","enrollment":1000},{"nctId":"NCT04653194","phase":"PHASE3","title":"Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'","status":"COMPLETED","sponsor":"Chelsea and Westminster NHS Foundation Trust","startDate":"2020-09-30","conditions":"Human Immunodeficiency Virus","enrollment":36},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT03809364","phase":"NA","title":"Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa","status":"COMPLETED","sponsor":"University of Maryland, College Park","startDate":"2021-11-01","conditions":"Human Immunodeficiency Virus","enrollment":40},{"nctId":"NCT01791556","phase":"NA","title":"Clinic-based ART Diagnostic Evaluation","status":"COMPLETED","sponsor":"Walter Reed Army Institute of Research (WRAIR)","startDate":"2010-01-26","conditions":"Acquired Immunodeficiency Syndrome, HIV Infection, RNA Virus Infections","enrollment":820},{"nctId":"NCT04249037","phase":"PHASE4","title":"Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2020-12-15","conditions":"HIV/AIDS","enrollment":10},{"nctId":"NCT02407691","phase":"NA","title":"Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South Africa","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2015-04","conditions":"HIV/AIDS, Depression, Chronic Diseases of Lifestyle","enrollment":2002}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard-of-care Antiretroviral therapy","genericName":"Standard-of-care Antiretroviral therapy","companyName":"Medical Research Council","companyId":"medical-research-council","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard-of-care antiretroviral therapy suppresses HIV replication by targeting viral enzymes (reverse transcriptase, protease, integrase) and entry mechanisms to reduce viral load and restore immune function. Used for HIV-1 infection (treatment and prevention), AIDS (acquired immunodeficiency syndrome).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}